Novel Compounds as SARS-CoV-2 Main Protease Inhibitors for Treating Viral Infections, in particular, Coronavirus Infections

ACS Medicinal Chemistry Letters 2026 Open access

Read full text
Authors: Ram W. Sabnis
DOI: 10.1021/acsmedchemlett.6c00285
Cited by: 1
References: 6

Abstract

Provided herein are novel compounds as main protease inhibitors, pharmaceutical compositions, use of such compounds in treating viral infections, in particular, coronavirus infections, and processes for preparing such compounds.

Fields of Study & Subjects

Diverse Scientific Research Studies Computational Drug Discovery Methods Pharmacological Receptor Mechanisms and Effects

Publication details

Journal / source
ACS Medicinal Chemistry Letters
Publisher
American Chemical Society (ACS)
Volume
17
Issue
7
Pages
1468–1470
Publication date
8 June 2026
Language
EN